Orphanet provides information on clinical trials focused on a rare disease or on a group of rare diseases. Trials comprise interventional studies aiming to evaluate a drug (or a combination of drugs or a biological product?) to treat (or prevent) a rare disease or a group of rare diseases. Single-centre and national or international multicentric clinical trials are registered. The trials registered in the Orphanet can be ongoing, recruiting, or finished (only the trials that have ended within the past 5 years are shown).
|Location||Worldwide- Available to Australians|